Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has presented new phase I clinical data for its cancer therapy candidate HMBD ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

The notification issued on Monday said the decision to waive development charges and development cess was based on an order ...

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with each other. The discovery shows the way toward future medications to combat, ...

Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases April 20, 2026 8:30 AM ...

The Dartmouth Cancer Center's new program will look at climate change’s impact on cancer development and treatment as well as ...

Yet one simple habit continues to make a lasting difference: reading together. Reading aloud to children can be an accessible ...

A discovery by the Transformation and Metastasis Group of the Spanish National Cancer Research Center (CNIO) opens a path ...

Pharmaceutical powerhouse Eli Lilly & Co. will buy Boston gene therapy maker Kelonia Therapeutics for at least $3.25 billion, ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

As one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread ...

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in ...